Since cartilage volume is a known determinant of cartilage defects, defect analyses have subsequently been adjusted for cartilage volume.
The initial paricalcitol dose was determined according to the baseline iPTH levels and subsequently was adjusted based on the serum PTH, Ca and P levels.
Subsequently, the resulting OD600 should be adjusted to 0.6 0.8 or to 106 108 cells × ml−1.
First, crude effects were estimated, and subsequently they were adjusted to confounders.
Subsequently analyses were adjusted for IP related factors associated with log NT-pro-BNP in our cross-sectional analysis.
Subsequently, pH was adjusted by adding 100 μL of 100 mM sodium acetate, pH 5.2, exactly the same portion of the labeling reagents was added again, and samples were incubated at 20°C for 15 min.
Subsequently, the pH was adjusted to approximately 9.5 by adding NaOH (0.1 M) solution and a new downward titration with zeta-potential measurement was started.
Briefly, the biosurfactant was resuspended in PBS (pH 7.0) to a concentration of 10 g l-1, and subsequently the pH was adjusted to 2.0 by adding HCl 1 M.
Subsequently, the threshold was adjusted until only the space between the cardiomyocytes was highlighted.
Subsequently, the treadmill was adjusted to a 10 degree uphill grade.
